Oscar Health, Inc. (NYSE:OSCR) Director Sells $426,250.00 in Stock

Oscar Health, Inc. (NYSE:OSCR) Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the transaction, the director now owns 89,512 shares in the company, valued at $1,526,179.60. This trade represents a 21.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Oscar Health Trading Down 2.0 %

Shares of OSCR stock opened at $15.98 on Monday. Oscar Health, Inc. has a 12-month low of $7.29 and a 12-month high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a 50 day moving average of $17.90 and a 200-day moving average of $18.18. The firm has a market cap of $3.95 billion, a P/E ratio of -266.33 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company’s quarterly revenue was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.29) earnings per share. Sell-side analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On Oscar Health

A number of large investors have recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new stake in Oscar Health during the second quarter valued at about $78,000. Quest Partners LLC bought a new stake in shares of Oscar Health in the 2nd quarter worth approximately $93,000. KBC Group NV increased its position in Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares during the period. Amalgamated Bank raised its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors purchased a new position in shares of Oscar Health in the 3rd quarter valued at approximately $142,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. UBS Group began coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reiterated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.